Jaw avascular bone necrosis associated with long-term use of biphosphonates
Open Access
- 22 April 2005
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 16 (7) , 1207-1208
- https://doi.org/10.1093/annonc/mdi206
Abstract
Bisphosphonates are currently used to prevent bone complications and to treat malignant hypercalcemia in patients with multiple myeloma, or bone metastases from breast and prostate cancers [1].Keywords
This publication has 4 references indexed in Scilit:
- Bisphosphonates: Preclinical ReviewThe Oncologist, 2004
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003